China Spatial Market
China Spatial Market was valued at US$ 45.25 Mn in 2021, estimated to reach US$ 165.55 Mn in 2027, with a CAGR of 18.44% from 2022-2027.
Proteomics, epigenomics, transcriptomics, genomics, metabolomics, and lipidomic are all parts of spatial omics. Spatial omics integrates molecular analysis with geographic data pertaining to a cell's position inside a tissue. Thus, this technology offers a potent tool for investigating crucial phenomena including tissue structure and cell control.
Market Drivers
Rising Prevalence of diseases.
The rising prevalence of diverse genetic illnesses, breakthroughs in sequencing technology, and increased financing for spatial omics research are all driving drivers in the market.
This unique technique allows researchers to gain a deeper understanding of the mechanisms that govern specific cell interactions at the tumour boundary, which is extremely useful in the early diagnosis of cancer. Furthermore, new advanced equipment introduced by medical device manufacturers will be responsible for an increase in research into the potential of spatial OMICS as a cancer diagnosis tool, which will assist to fuel the market's expansion.
Market Restraints
Lack of skilled professionals
However, two market constraints are the paucity of computational analytical tools and the substantial financial expenditure required for worldwide expansion. Furthermore, a modest rate of technological improvement may stifle market growth for spatial omics solutions.
Spatial omics is a relatively recent field of study, with most of the global development of spatial transcriptomics research taking place in and other affluent countries.
Impact of COVID-19
On December 31, 2019, a Coronavirus (COVID-19) epidemic was first detected in Wuhan, China. On March 11, 2020, the World Health Organization proclaimed COVID-19 a pandemic.
The Coronavirus states that (COVID-19). Covid-19 did have a detrimental influence on the spatial omics industry in the early days of its dissemination, with the company's revenue declining in the second quarter of 2020 as a result of widespread client lab closures due to lockdown. However, the impact was short-lived, and the company's income subsequently increased due to an increase in consumables revenue caused by an increase in instrument installed base.
Market Segmentation
The China Spatial Market is segmented into Technology, Product, Distribution Channel and Growing System. By Technology such as Spatial Transcriptomics, Spatial Genomics . By Product such as Instruments, Consumables, Software. By End-use such as Translational Research, Academic Customers, Diagnostic Customers, Pharmaceutical Manufacturer.
Regional Analysis
China Spatial market due to an increase in the Translational Research and Academic Customers segment in the region. China Spatial is expected to grow at significant growth rate, as end use such as Translational Research and Military Aircraft segment are growing in the country. This is attributed to the strategic investments in disease pathology research and the increased focus on transcriptomics R&D.
Key Players
Various key players are listed in this report such as 10x Genomics, Advanced Cell Diagnostics, Inc. (ACD), Horizon Discovery Ltd, Illumina, Inc, NanoString Technologies, Vizgen, Akoya Biosciences, Inc., Bio-Techne, Saimo, Danaher Corporation
Market Taxonomy
By Technology
By Product
By End-use
By Region
Key Questions Addressed by the Report
China Spatial Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 China Spatial Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 China Spatial Market, By Technology
5.1 Y-o-Y Growth Comparison, By Technology
5.2 China Spatial Market Share Analysis, By Technology
5.3 China Spatial Market Size and Forecast, By Technology
5.3.1 Spatial Transcriptomics
5.3.1.1 Sequencing-based Methods
5.3.1.1.1 Laser Capture Microdissection (LCM)
5.3.1.1.2 FFPE Tissue Sample
5.3.1.1.3 Others
5.3.1.2 Transcriptome In-vivo Analysis (TIVA) In Situ Sequencing
5.3.1.3 Microtomy Sequencing
5.3.1.2 Microscopy-based RNA Imaging Techniques
5.3.1.3 IHC
5.3.1.4 Single Molecule RNA Fluorescence In-situ Hybridization (smFISH) Padlock Probes/ Rolling Circle 5.3.1.5 Amplification
5.3.1.6 Branched DNA Probes
5.3.2 Spatial Genomics
5.3.2.1 FISH
5.3.2.2 Microscopy-based Live DNA Imaging
5.3.2.3 Genome Perturbation Tools
5.3.2.4 Massively-parallel Sequencing
5.3.2.5 Biochemical Techniques
5.3.2.6 Others
6 China Spatial Market, By Product
6.1 Y-o-Y Growth Comparison, By Product
6.2 China Spatial Market Share Analysis, By Product
6.3 China Spatial Market Size and Forecast, By Product
6.3.1 Instruments
6.3.1.1 By Mode
6.3.1.1.1 Automated
6.3.1.1.2 Semi-automated
6.3.1.1.3 Manual
6.3.1.2 by Type
6.3.1.2.1. Sequencing
6.3.1.2.2 Platforms IHC
6.3.1.2.3 Microscopy Flow
6.3.1.2.4 Cytometer
6.3.1.2.5 Mass Spectrometry
6.3.1.2.6 Others
6.3.2 Consumables
6.3.3 Software
6.3.3.1 Bioinformatics Tools
6.3.3.2 Imaging Tools
6.3.3.3 Storage and Management Databases
7 China Spatial Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 China Spatial Market Share Analysis, By End User
7.3 China Spatial Market Size and Forecast, By End User
7.3.1 Translational Research
7.3.2 Academic Customers
7.3.3 Diagnostic Customers
7.3.4 Pharmaceutical Manufacturer
8 Competitive Analysis
8.1 Competition Dashboard
8.2 Market share Analysis of Top Vendors
8.3 Key Development Strategies
9 Company Profiles
9.1 10x Genomics
9.1.1 Overview
9.1.2 Technologys
9.1.3 Key Financials
9.1.4 Business Segment & Geographic Overview
9.1.5 Key Market Developments
9.1.6 Key Strategies
9.2. Advanced Cell Diagnostics, Inc. (ACD)
9.2.1 Overview
9.2.2 Technologys
9.2.3 Key Financials
9.2.4 Business Segment & Geographic Overview
9.2.5 Key Market Developments
9.2.6 Key Strategies
9.3. Horizon Discovery Ltd
9.3.1 Overview
9.3.2 Technologys
9.3.3 Key Financials
9.3.4 Business Segment & Geographic Overview
9.3.5 Key Market Developments
9.3.6 Key Strategies
9.4 Illumina, Inc
9.4.1 Overview
9.4.2 Technologys
9.4.3 Key Financials
9.4.4 Business Segment & Geographic Overview
9.4.5 Key Market Developments
9.4.6 Key Strategies
9.5 NanoString Technologies
9.5.1 Overview
9.5.2 Technologys
9.5.3 Key Financials
9.5.4 Business Segment & Geographic Overview
9.5.5 Key Market Developments
9.5.6 Key Strategies
9.6 Vizgen
9.6.1 Overview
9.6.2 Technologys
9.6.3 Key Financials
9.6.4 Business Segment & Geographic Overview
9.6.5 Key Market Developments
9.6.6 Key Strategies
9.7 Akoya Biosciences, Inc.
9.7.1 Overview
9.7.2 Technologys
9.7.3 Key Financials
9.7.4 Business Segment & Geographic Overview
9.7.5 Key Market Developments
9.7.6 Key Strategies
9.8 Bio-Techne
9.8.1 Overview
9.8.2 Technologys
9.8.3 Key Financials
9.8.4 Business Segment & Geographic Overview
9.8.5 Key Market Developments
9.8.6 Key Strategies
9.9 Saimo
9.9.1 Overview
9.9.2 Technologys
9.9.3 Key Financials
9.9.4 Business Segment & Geographic Overview
9.9.5 Key Market Developments
9.9.6 Key Strategies
9.10 Danaher Corporation
9.10.1 Overview
9.10.2 Technologys
9.10.3 Key Financials
9.10.4 Business Segment & Geographic Overview
9.10.5 Key Market Developments
9.10.6 Key Strategies
